Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 10: 10th International Consensus Conference on Outcome Measures in Rheumatology, Kota Kinabalu, Borneo - May 4–8, 2010

The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) Is Reliable and Sensitive to Change: Results from an OMERACT Workshop

PERNILLE BØYESEN, FIONA M. McQUEEN, FRÉDÉRIQUE GANDJBAKHCH, SIRI LILLEGRAVEN, LAURA COATES, CHARLOTTE WIELL, ESPEN A. HAAVARDSHOLM, PHILIP G. CONAGHAN, CHARLES G. PETERFY, PAUL BIRD and MIKKEL ØSTERGAARD
The Journal of Rheumatology September 2011, 38 (9) 2034-2038; DOI: https://doi.org/10.3899/jrheum.110420
PERNILLE BØYESEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pernilleboyesen{at}gmail.com
FIONA M. McQUEEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRÉDÉRIQUE GANDJBAKHCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIRI LILLEGRAVEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAURA COATES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLOTTE WIELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ESPEN A. HAAVARDSHOLM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIP G. CONAGHAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLES G. PETERFY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL BIRD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIKKEL ØSTERGAARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Magnetic resonance imaging examples of PsAMRIS’s sensitivity to change during anti-TNF-α treatment. The T1-weighted images show before (A and B) and after (C and D) gadolinium injection. Baseline MR images of PIP-3 (A and B) show periarticular inflammation (broad arrow, B) and synovitis (narrow arrow, B). After 12 months with anti-TNF-α treatment (C and D) the periarticular inflammation and synovitis of the PIP-3 resolved.

Tables

  • Figures
    • View popup
    Table 1.

    Patients included in the Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) workshop.

    Copenhagen, n = 8Leeds, n = 4PsAMRIS Features
    TreatmentAnti-TNF-αDMARD
    Assessment timepoints0 and 12 months0 and 12 months
    Field strength0.6 T0.2 T
    MRI sequences applied
      T1w pre-Gd injectionxxBone erosions, bone proliferation, n = 12
      T1w post-Gd injectionxSynovitis, tenosynovitis, periarticular inflammation, n = 8
      STIRxBone marrow edema, n = 8
    • TNF-α: tumor necrosis factor-α; DMARD: disease-modifying antirheumatic drugs; MRI: magnetic resonance imaging; T1w: t1 weighted MRI sequence; Gd: Gadolinium; STIR: short-tau inversion recovery.

    • View popup
    Table 2.

    Median (minimum, maximum) baseline and 1-year change in PsAMRIS features for overall scores and subjoint regions. All values are given as median (minimum to maximum) of the 4 scorers’ median scores.

    PsAMRIS Features (range of total score)Baseline PsAMRISOne-year Change in PsAMRIS
    Total scoreMCPPIPDIPTotal scoreMCPPIPDIP
    Synovitis (0–36)11.3 (3.5 to 13)3.0 (1.0 to 4.5)4.0 (1.5 to .0)0.75 (0.0 to 3.0)−1.5 (−11.0 to 3.5)−1.75 (−5.0 to 1.5)0.0 (−6.0 to 3.0)−0.25 (−2.5 to 2.5)
    Flexor tenosynovitis (0–36)5.3 (0.0 to 6.5)1.25 (0.0 to 5.0)0.0 (0.0 to 2.0)0.0 (0.0 to 1.0)−2.0 (−9.0 to 1.5)−0.75 (−3.0 to 2.0)−1.0 (−3.5 to 0.0)0.0 (−2.0 to 0.0)
    Periarticular inflammation (0–24)0.3 (0.0 to 1.5)0.0 (0.0 to 0.0)0.0 (0.0 to 1.5)0.0 (0.0 to 0.5)−0.25 (−4.0 to 0.0)0.0 (−0.5 to 0.0)−0.25 (−3.5 to 0.0)0.0 (−1.0 to 0.0)
    Bone marrow edema (0–72)0.0 (0.0 to 1.5)0.0 (0.0 to 1.0)0.0 (0.0 to 0.5)0.0 (0.0 to 0.0)0.0 (−9.0 to 1.5)0.0 (−1.5 to 1.0)0.0 (−4.5 to 0.0)0.0 (−2.5 to 0.0)
    Bone erosion (0–240)2.0 (0.0 to 6.5)1.5 (0.0 to 5.0)0.0 (0.0 to 2.5)0.0 (0.0 to 0.5)0.0 (−0.5 to 1.0)0.0 (0.0 to 1.0)0.0 (−0.5 to 0.0)0.0 (0.0 to 0.5)
    Bone proliferation (0–12)3.0 (0.0 to 5.0)0.0 (0.0 to 1.5)0.0 (0.0 to 2.0)0.75 (0.0 to 4.0)0.0 (−0.5 to 0.5)0.0 (0.0 to 0.0)0.0 (0.0 to 0.0)0.0 (0.0 to 0.0)
    • PsAMRIS: psoriatic arthritis magnetic resonance imaging score; MCP: metacarpophalangeal joint; PIP: proximal interphalangeal joint; DIP: distal interphalangeal joint.

    • View popup
    Table 3A.

    Inter- and intrareader reliability for PsAMRIS status and change scores. Intraclass correlation coefficients. Key to SRM values: Very good, ICC ≥ 0.80; good, 0.50 ≤ ICC < 0.80; poor, 0.20 ≤ ICC < 0.50; trivial, ICC < 0.20.

    Interreader Reliability, ICCaIntrareader Reliability, ICCs
    Reader 1Reader 2Reader 3Reader 4
    PsAMRIS FeaturesStatusChangeStatusChangeStatusChangeStatusChangeStatusChange
    Synovitis0.950.950.970.780.730.630.930.650.900.38
    Flexor tenosynovitis0.970.950.810.920.740.730.930.800.730.90
    Bone proliferation0.770.100.200.260.840.870.790.730.440.46
    Periarticular inflammation0.910.910.39NA*0.95NA*0.880.330.91NA*
    Bone marrow edema0.870.870.980.630.970.130.991.000.030.80
    Bone erosion0.970.440.910.940.930.910.920.910.910.88
    • ↵* Not calculable because zero variance. ICCa: average measure intraclass correlation coefficient; ICCs: single measure intraclass correlation coefficient; PsAMRIS: psoriatic arthritis magnetic resonance imaging score.

    • View popup
    Table 3B.

    Inter- and intrareader reliability for PsAMRIS status and change scores. Smallest detectable difference and change.

    Interreader Reliability (SDD/SDC)Intrareader Reliability (SDD/SDC)*
    PsAMRIS FeaturesStatus ScoresChange ScoresStatus ScoresChange Scores
    SDDSDD%maxSDDSDD%maxSDDSDD%maxSDDSDD%max
    Synovitis2.7813.893.1913.283.5427.624.7132.17
    Flexor tenosynovitis3.3527.912.9719.794.7145.274.0842.10
    Periarticular inflammation2.1135.182.4326.982.1733.792.0230.65
    Bone marrow edema1.299.242.0015.421.7616.072.6641.64
    Bone erosion1.3819.660.8421.051.7924.441.2942.99
    Bone proliferation2.6232.710.5718.942.7457.680.9270.08
    • ↵* Median values of the 4 readers. SDD: smallest detectable differences; SDC: smallest detectable change; PsAMRIS: psoriatic arthritis magnetic resonance imaging score.

    • View popup
    Table 4.

    Sensitivity to change of the PsAMRIS measured by standardized response means (SRM). Key to SRM values: large, SRM ≥ 0.80; moderate, 0.50 ≤ SRM < 0.80; small, 0.20 ≤ SRM < 0.50; trivial, SRM < 0.20.

    Standardized Response Mean
    PsAMRIS FeaturesTotal ScoreMCP JointsPIP JointsDIP Joints
    Synovitis−0.50−0.77−0.28−022
    Flexor tenosynovitis−0.79−0.53−0.97−0.57
    Periarticular inflammation−0.54−0.47−0.44−0.72
    Bone marrow edema−0.34−0.08−0.46−0.31
    Bone erosion0.220.52−0.530.00
    Bone proliferation−0.11−0.29NA*0.16
    • ↵* Not calculated because zero variance. PsAMRIS: psoriatic arthritis magnetic resonance imaging score; MCP: metacarpophalangeal joint; PIP: proximal interphalangeal joint; DIP: distal interphalangeal joint.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 9
1 Sep 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) Is Reliable and Sensitive to Change: Results from an OMERACT Workshop
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) Is Reliable and Sensitive to Change: Results from an OMERACT Workshop
PERNILLE BØYESEN, FIONA M. McQUEEN, FRÉDÉRIQUE GANDJBAKHCH, SIRI LILLEGRAVEN, LAURA COATES, CHARLOTTE WIELL, ESPEN A. HAAVARDSHOLM, PHILIP G. CONAGHAN, CHARLES G. PETERFY, PAUL BIRD, MIKKEL ØSTERGAARD
The Journal of Rheumatology Sep 2011, 38 (9) 2034-2038; DOI: 10.3899/jrheum.110420

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) Is Reliable and Sensitive to Change: Results from an OMERACT Workshop
PERNILLE BØYESEN, FIONA M. McQUEEN, FRÉDÉRIQUE GANDJBAKHCH, SIRI LILLEGRAVEN, LAURA COATES, CHARLOTTE WIELL, ESPEN A. HAAVARDSHOLM, PHILIP G. CONAGHAN, CHARLES G. PETERFY, PAUL BIRD, MIKKEL ØSTERGAARD
The Journal of Rheumatology Sep 2011, 38 (9) 2034-2038; DOI: 10.3899/jrheum.110420
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

OMERACT 10: 10th International Consensus Conference on Outcome Measures in Rheumatology, Kota Kinabalu, Borneo - May 4–8, 2010

  • Patterns of Magnetic Resonance Imaging Bone Erosion in Rheumatoid Arthritis — Which Bones Are Most Frequently Involved and Show the Most Change?
  • Synovial Tissue Analysis for the Discovery of Diagnostic and Prognostic Biomarkers in Patients with Early Arthritis
  • OMERACT 10 Sharp Symposium: Important Findings in Examination of Imaging Methods for Measurement of Joint Damage in Rheumatoid Arthritis
Show more OMERACT 10: 10th International Consensus Conference on Outcome Measures in Rheumatology, Kota Kinabalu, Borneo - May 4–8, 2010

Biomarker and Imaging Outcomes

  • Magnetic Resonance Imaging in Rheumatoid Arthritis Clinical Trials: Emerging Patterns Based on Recent Experience
  • Damage and Progression on Radiographs in Individual Joints: Data from Pivotal Randomized Controlled Trials
  • Development and Preliminary Validation of a Magnetic Resonance Imaging Joint Space Narrowing Score for Use in Rheumatoid Arthritis: Potential Adjunct to the OMERACT RA MRI Scoring System
Show more Biomarker and Imaging Outcomes

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire